MIRIMICHI GREEN, LLC – Trademark Portfolio

Entity Type: 16

MIRIMICHI GREEN, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MIRIMICHI GREEN. The owner is based in LOS ANGELES, CA.

10960 WILSHIRE BLVD.

FIFTH FLOOR

LOS ANGELES, CA 90024

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MIRIMICHI GREEN, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does MIRIMICHI GREEN, LLC have?

MIRIMICHI GREEN, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 2 cancelled.

What trademark classes does MIRIMICHI GREEN, LLC file in?

MIRIMICHI GREEN, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MIRIMICHI GREEN, LLC's most well-known trademarks?

MIRIMICHI GREEN, LLC's registered trademark portfolio includes well-known marks such as MIRIMICHI GREEN. These are among 2 currently registered trademarks in the portfolio.

What is MIRIMICHI GREEN, LLC's trademark registration success rate?

MIRIMICHI GREEN, LLC has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.